Yes, thats what i said
the issue is that BUBS hasn't identified the CNCA manufacturer who will register their formulation.....whilst they "have confidence the will make registration be end Q2".....based on what?
there is one other issue in that CFDA formulation registration will also take into consideration previous general import sales into china.......and BUBS dont have any (but then again either do wattle health).....CFDA formulation registration is basically at CFDA's discretion......and that is where Brilite MAY be able to help with some liberal Guanxi on the ground.......
The JD woman is irrelevant, as is Albert Tse.....they are nice Christmas baubles.....
i wish them luck, honestly. The more Australia companies developing business in china the better..
- Forums
- ASX - By Stock
- BUB
- Capital Raising Offer to Limited Parties
Capital Raising Offer to Limited Parties, page-167
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
13.3¢ |
Change
-0.003(1.85%) |
Mkt cap ! $118.2M |
Open | High | Low | Value | Volume |
13.5¢ | 13.5¢ | 13.0¢ | $144.0K | 1.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 2050904 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
13.5¢ | 133162 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 2050904 | 0.130 |
52 | 3909215 | 0.125 |
73 | 4005116 | 0.120 |
32 | 1757863 | 0.115 |
37 | 880026 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.135 | 130458 | 10 |
0.140 | 977933 | 26 |
0.145 | 536511 | 18 |
0.150 | 1047084 | 32 |
0.155 | 205824 | 11 |
Last trade - 15.12pm 15/07/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online